ProShare Advisors’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $469K | Sell |
6,583
-1,489
| -18% | -$102K | ﹤0.01% | 1101 |
|
|
2025
Q4 | $478K | Buy |
8,072
+460
| +6% | +$25K | ﹤0.01% | 1149 |
|
|
2025
Q3 | $420K | Sell |
7,612
-1,271
| -14% | -$66.1K | ﹤0.01% | 1212 |
|
|
2025
Q2 | $383K | Sell |
8,883
-576
| -6% | -$22.2K | ﹤0.01% | 1278 |
|
|
2025
Q1 | $374K | Sell |
9,459
-2,399
| -20% | -$106K | ﹤0.01% | 1262 |
|
|
2024
Q4 | $483K | Buy |
11,858
+3,595
| +44% | +$150K | ﹤0.01% | 1289 |
|
|
2024
Q3 | $322K | Buy |
8,263
+2,027
| +33% | +$80.7K | ﹤0.01% | 1422 |
|
|
2024
Q2 | $273K | Sell |
6,236
-1,707
| -21% | -$82.5K | ﹤0.01% | 1352 |
|
|
2024
Q1 | $379K | Buy |
7,943
+508
| +7% | +$22.8K | ﹤0.01% | 1267 |
|
|
2023
Q4 | $351K | Buy |
7,435
+1,091
| +17% | +$45.3K | ﹤0.01% | 1269 |
|
|
2023
Q3 | $302K | Sell |
6,344
-259
| -4% | -$14.1K | ﹤0.01% | 1205 |
|
|
2023
Q2 | $384K | Sell |
6,603
-830
| -11% | -$49.8K | ﹤0.01% | 1113 |
|
|
2023
Q1 | $532K | Buy |
7,433
+442
| +6% | +$35.1K | ﹤0.01% | 890 |
|
|
2022
Q4 | $492K | Buy |
6,991
+825
| +13% | +$58.2K | ﹤0.01% | 969 |
|
|
2022
Q3 | $374K | Sell |
6,166
-2,238
| -27% | -$150K | ﹤0.01% | 1031 |
|
|
2022
Q2 | $530K | Sell |
8,404
-4,460
| -35% | -$291K | ﹤0.01% | 925 |
|
|
2022
Q1 | $824K | Sell |
12,864
-1,985
| -13% | -$133K | ﹤0.01% | 998 |
|
|
2021
Q4 | $1.07M | Buy |
14,849
+4,083
| +38% | +$311K | ﹤0.01% | 983 |
|
|
2021
Q3 | $768K | Sell |
10,766
-6,115
| -36% | -$482K | ﹤0.01% | 1002 |
|
|
2021
Q2 | $1.37M | Buy |
16,881
+629
| +4% | +$50.6K | ﹤0.01% | 863 |
|
|
2021
Q1 | $1.23M | Buy |
16,252
+2,024
| +14% | +$147K | ﹤0.01% | 887 |
|
|
2020
Q4 | $1.08M | Buy |
14,228
+4,677
| +49% | +$305K | ﹤0.01% | 844 |
|
|
2020
Q3 | $472K | Sell |
9,551
-191
| -2% | -$10.8K | ﹤0.01% | 971 |
|
|
2020
Q2 | $512K | Buy |
+9,742
| New | +$462K | ﹤0.01% | 937 |
|
|
2020
Q1 | – | Sell |
-11,705
| Closed | -$1.02M | – | 1438 |
|
|
2019
Q4 | $1.02M | Buy |
11,705
+1,017
| +10% | +$88.9K | ﹤0.01% | 791 |
|
|
2019
Q3 | $907K | Buy |
10,688
+281
| +3% | +$25K | 0.01% | 774 |
|
|
2019
Q2 | $1.09M | Sell |
10,407
-182
| -2% | -$18.3K | 0.01% | 730 |
|
|
2019
Q1 | $1.12M | Buy |
10,589
+2,408
| +29% | +$242K | 0.01% | 721 |
|
|
2018
Q4 | $685K | Sell |
8,181
-1,014
| -11% | -$91.8K | ﹤0.01% | 830 |
|
|
2018
Q3 | $937K | Sell |
9,195
-1,000
| -10% | -$96.5K | 0.01% | 849 |
|
|
2018
Q2 | $824K | Buy |
10,195
+89
| +0.9% | +$7.07K | 0.01% | 899 |
|
|
2018
Q1 | $745K | Sell |
10,106
-699
| -6% | -$52.3K | ﹤0.01% | 941 |
|
|
2017
Q4 | $761K | Buy |
10,805
+4,568
| +73% | +$330K | 0.01% | 946 |
|
|
2017
Q3 | $390K | Sell |
6,237
-763
| -11% | -$45.2K | ﹤0.01% | 1052 |
|
|
2017
Q2 | $402K | Sell |
7,000
-2,067
| -23% | -$122K | ﹤0.01% | 1036 |
|
|
2017
Q1 | $552K | Sell |
9,067
-1,970
| -18% | -$111K | 0.01% | 970 |
|
|
2016
Q4 | $605K | Buy |
11,037
+2,842
| +35% | +$136K | 0.01% | 985 |
|
|
2016
Q3 | $378K | Sell |
8,195
-1,462
| -15% | -$61.7K | 0.01% | 1062 |
|
|
2016
Q2 | $329K | Buy |
+9,657
| New | +$302K | ﹤0.01% | 1162 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
ProShare Advisors's NGVT Position: Q1 2026 in Review
ProShare Advisors reduced its Ingevity (NGVT) stake by 18% in Q1 2026, selling an estimated $102K and leaving 6,583 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.
ProShare Advisors first reported a position in NGVT in Q2 2016 and has held it in 39 quarters since. The position peaked at $1.37M in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- ProShare Advisors held 6,583 shares of Ingevity worth $469K as of Q1 2026.
- ProShare Advisors sold 1,489 Ingevity shares in Q1 2026, an estimated $102K.
- Ingevity made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1101 holding.
- ProShare Advisors first reported a position in Ingevity in Q2 2016 and has held it in 39 quarters since.
- ProShare Advisors's Ingevity position peaked at $1.37M in Q2 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.